U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187291187291MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableChronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndrome|Leukemia|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome|Untreated Adult Acute Myeloid Drug: Azacitidine|Drug: Entinostathttps://ClinicalTrials.gov/show/NCT00101179
187292187292Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaCompletedHas ResultsMelanoma (Skin)Biological: Bystander-Based Autologous Tumor Cell Vaccinehttps://ClinicalTrials.gov/show/NCT00101166
187293187293Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaDrug: cytarabine|Drug: daunorubicin hydrochloride|Drug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00101153
187294187294Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionWithdrawnNo Results AvailableAdult Acute Erythroid Leukemia|Adult Acute Monoblastic and Acute Monocytic Leukemia|Adult Acute Myeloid LeukemiaDrug: anti-thymocyte globulin|Drug: fludarabine phosphate|Drug: thiotepa|Procedure: biological therapy|Procedure: bone marrow ablation with stem cell support|Procedure: chemotherapy|Procedure: non-specific immune-modulator therapy|Procedure: peripheral blood stem cell transplantation|Procedure: radiation therapyhttps://ClinicalTrials.gov/show/NCT00101140
187295187295Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNo Results AvailableSarcomaBiological: filgrastim|Biological: pegfilgrastim|Drug: docetaxel|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00101127
187296187296Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNo Results AvailableClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell CancerDrug: sorafenib tosylate|Biological: recombinant interferon alfa-2b|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00101114
187297187297Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell LymphomaActive, not recruitingHas ResultsLymphomaDrug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: Dexamethasone|Biological: Autologous Tumor Cell-Based Vaccine|Drug: IL-2https://ClinicalTrials.gov/show/NCT00101101
187298187298Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia|Relapsing Chronic Myelogenous LeukemiaDrug: imatinib mesylate|Drug: temsirolimus|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00101088
187299187299Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By SurgeryActive, not recruitingNo Results AvailableHead and Neck CancerDrug: capecitabine|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00101075
187300187300Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerTerminatedNo Results AvailableBreast CancerDrug: celecoxib|Drug: letrozolehttps://ClinicalTrials.gov/show/NCT00101062
187301187301Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By SurgeryCompletedHas ResultsAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable ExtrahepatiDrug: lapatinib ditosylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00101036
187302187302Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell LymphomaCompletedNo Results AvailableLymphomaBiological: Filgrastim|Biological: Pegfilgrastim|Biological: Rituximab|Drug: Cyclophosphamide|Drug: Pegylated liposomal doxorubicin hydrochloride|Drug: Prednisone|Drug: Vincristine Sulfatehttps://ClinicalTrials.gov/show/NCT00101010
18730318730317-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib MesylateCompletedNo Results AvailableLeukemiaDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00100997
187304187304A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1TerminatedNo Results AvailableHIV InfectionDrug: FUZEON [enfuvirtide]https://ClinicalTrials.gov/show/NCT00100984
187305187305Vaccine Therapy in Treating Patients With Acute Myeloid LeukemiaTerminatedNo Results AvailableLeukemiaDrug: autologous tumor cell vaccine|Drug: therapeutic autologous dendritic cells|Procedure: tumor cell-derivative vaccine therapyhttps://ClinicalTrials.gov/show/NCT00100971
187306187306Indole-3-Carbinol in Preventing Cancer in Healthy ParticipantsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: indole-3-carbinolhttps://ClinicalTrials.gov/show/NCT00100958
187307187307Gefitinib in Treating Patients With Locally Advanced Esophageal CancerCompletedNo Results AvailableEsophageal CancerDrug: gefitinibhttps://ClinicalTrials.gov/show/NCT00100945
187308187308Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet ChemotherapyCompletedHas ResultsNon-Small-Cell Lung CarcinomaDrug: E7389 28 Day Cycle|Drug: E7389 21 Day Cyclehttps://ClinicalTrials.gov/show/NCT00100932
187309187309Sensing of Leg Position and MovementCompletedNo Results AvailableProprioceptionhttps://ClinicalTrials.gov/show/NCT00100919
187310187310Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerCompletedNo Results AvailableKidney CancerDrug: IL-2|Drug: ATRAhttps://ClinicalTrials.gov/show/NCT00100906
187311187311IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast CancerCompletedNo Results AvailableBreast CancerDietary Supplement: IH636 grape seed proanthocyanidin extracthttps://ClinicalTrials.gov/show/NCT00100893
187312187312Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNo Results AvailableChildhood Atypical Teratoid/Rhabdoid Tumor|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade IIDrug: lenalidomide|Procedure: perfusion-weighted magnetic resonance imaging|Procedure: diffusion-weighted magnetic resonance imaging|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00100880
187313187313Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected WomenCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00100867
187314187314Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableLung CancerDrug: erlotinib hydrochloride|Drug: fulvestranthttps://ClinicalTrials.gov/show/NCT00100854
187315187315Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerCompletedHas ResultsAdenocarcinoma of the Rectum|Mucinous Adenocarcinoma of the Colon|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Stage IV Colon Cancer|Stage IV Rectal CancerBiological: cetuximab|Biological: bevacizumab|Drug: oxaliplatin|Drug: leucovorin calcium|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00100841
187316187316Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid CancerCompletedNo Results AvailableHead and Neck CancerDrug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00100828
187317187317Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: capecitabine|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00100815
187318187318Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed GliomasActive, not recruitingNo Results AvailableBrain Tumors|Central Nervous System TumorsDrug: lomustine|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00100802
187319187319S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedHas ResultsHead and Neck CancerDrug: gemcitabine|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00100789
187320187320Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: Olanzapinehttps://ClinicalTrials.gov/show/NCT00100776

* Görseller ve İçerik tekif hakkına sahip olabilir